statistiche ricercatore

Continente	#
NA - Nord America	981
AS - Asia	363
EU - Europa	331
SA - Sud America	79
Continente sconosciuto - Info sul continente non disponibili	70
AF - Africa	26
Totale	1.850

Nazione	#
US - Stati Uniti d'America	956
SG - Singapore	131
IT - Italia	117
CN - Cina	69
BR - Brasile	65
RU - Federazione Russa	46
HK - Hong Kong	43
DE - Germania	37
SE - Svezia	34
VN - Vietnam	33
FR - Francia	27
FI - Finlandia	20
BD - Bangladesh	17
IN - India	16
CA - Canada	14
GB - Regno Unito	14
CI - Costa d'Avorio	12
ID - Indonesia	10
PH - Filippine	10
JP - Giappone	7
MX - Messico	7
NL - Olanda	7
UA - Ucraina	7
IQ - Iraq	5
TR - Turchia	5
KE - Kenya	4
AT - Austria	3
CO - Colombia	3
EC - Ecuador	3
IR - Iran	3
LT - Lituania	3
PT - Portogallo	3
PY - Paraguay	3
UZ - Uzbekistan	3
VE - Venezuela	3
AO - Angola	2
CH - Svizzera	2
EG - Egitto	2
ES - Italia	2
MY - Malesia	2
PK - Pakistan	2
PL - Polonia	2
TN - Tunisia	2
TT - Trinidad e Tobago	2
ZA - Sudafrica	2
AE - Emirati Arabi Uniti	1
BE - Belgio	1
BG - Bulgaria	1
BY - Bielorussia	1
CL - Cile	1
GM - Gambi	1
GT - Guatemala	1
HR - Croazia	1
IE - Irlanda	1
IL - Israele	1
KG - Kirghizistan	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
MA - Marocco	1
RO - Romania	1
SA - Arabia Saudita	1
SI - Slovenia	1
TW - Taiwan	1
UY - Uruguay	1
VC - Saint Vincent e Grenadine	1
Totale	1.780

Nome	#
Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis	372
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis	188
Cerebrospinal fluid neurofilament light chain levels: marker of progression to generalized amyotrophic lateral sclerosis	175
Host-Cell Type Dependent Features of Recombinant Human Aquaporin-4 Orthogonal Arrays of Particles-New Insights for Structural and Functional Studies	175
Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of Multiple Sclerosis	165
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience	156
Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis	154
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method	124
Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A	111
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity	102
null	62
The role of serum neurofilament light chain in an adult cohort of patients with acquired demyelinating syndromes of the central nervous system (P2-4.006)	35
Serum neurofilament light chain in a cohort of multiple sclerosis, MOG-antibody diseases and neuromyelitis optica spectrum disorders patients	31
Totale	1.850

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	68	0	0	4	2	3	8	2	3	8	4	11	23
2022/2023	131	13	20	11	13	18	12	1	14	19	0	3	7
2023/2024	46	3	7	3	3	2	10	1	5	0	2	0	10
2024/2025	294	13	4	13	8	13	21	34	36	18	31	40	63
2025/2026	756	95	36	58	68	90	49	72	30	97	75	34	52
2026/2027	194	140	23	31	0	0	0	0	0	0	0	0	0
Totale													1.850